메뉴 건너뛰기




Volumn 117, Issue 6, 2011, Pages 1799-1805

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

(24)  Montesinos, Pau a   Rayón, Chelo b   Vellenga, Edo c   Brunet, Salut d   González, José e   González, Marcos f   Holowiecka, Aleksandra g   Esteve, Jordi h   Bergua, Juan i   González, José D j   Rivas, Concha k   Tormo, Mar l   Rubio, Vicente m   Bueno, Javier n   Manso, Félix o   Milone, Gustavo p   De La Serna, Javier q   Pérez, Inmaculada r   Pérez Encinas, Manuel s   Krsnik, Isabel t   more..


Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTHRACYCLINE; CD15 ANTIGEN; CD2 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYTARABINE; HLA DR ANTIGEN; IDARUBICIN; MITOXANTRONE; RETINOIC ACID; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE ANTIGEN;

EID: 79951503141     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-277434     Document Type: Article
Times cited : (106)

References (29)
  • 1
    • 0032923932 scopus 로고    scopus 로고
    • CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome?
    • Murray CK, Estey E, Paietta E, et al. CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? J Clin Oncol. 1999;17(1):293-297.
    • (1999) J Clin Oncol , vol.17 , Issue.1 , pp. 293-297
    • Murray, C.K.1    Estey, E.2    Paietta, E.3
  • 4
    • 33645387266 scopus 로고    scopus 로고
    • The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes
    • Albano F, Mestice A, Pannunzio A, et al. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. Haematologica. 2006;91(3):311-316.
    • (2006) Haematologica , vol.91 , Issue.3 , pp. 311-316
    • Albano, F.1    Mestice, A.2    Pannunzio, A.3
  • 7
    • 77954681398 scopus 로고    scopus 로고
    • Riskadapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome
    • Sanz MA, Montesinos P, Rayon C, et al. Riskadapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood. 2010;115(25):5137-5146.
    • (2010) Blood , vol.115 , Issue.25 , pp. 5137-5146
    • Sanz, M.A.1    Montesinos, P.2    Rayon, C.3
  • 8
    • 0028837561 scopus 로고
    • Proposals for the immunological classification of acute leukemias
    • European Group for the Immunological Characterization of Leukemias (EGIL)
    • Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9(10):1783-1786.
    • (1995) Leukemia , vol.9 , Issue.10 , pp. 1783-1786
    • Bene, M.C.1    Castoldi, G.2    Knapp, W.3
  • 12
    • 59649106888 scopus 로고    scopus 로고
    • Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: Characteristics, outcome, and prognostic factors
    • Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009;113(4):775-783.
    • (2009) Blood , vol.113 , Issue.4 , pp. 775-783
    • Montesinos, P.1    Bergua, J.M.2    Vellenga, E.3
  • 13
    • 77949733334 scopus 로고    scopus 로고
    • Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    • Cervera J, Montesinos P, Hernández-Rivas JM, et al. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Haematologica. 2010;95(3):424-431.
    • (2010) Haematologica , vol.95 , Issue.3 , pp. 424-431
    • Cervera, J.1    Montesinos, P.2    Hernández-Rivas, J.M.3
  • 15
    • 33845382806 scopus 로고
    • Nonparametric estimations from incomplete observations
    • Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 16
    • 0013886333 scopus 로고
    • Evaluation of survival data and two new rank order statistics arising in its consideration
    • Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163-170.
    • (1966) Cancer Chemother Rep , vol.50 , Issue.3 , pp. 163-170
    • Mantel, N.1
  • 17
    • 0000120995 scopus 로고
    • A class of K-sample test for comparing the cumulative incidence of a competing risk
    • Gray RJ. A class of K-sample test for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141-1154.
    • (1988) Ann Stat , vol.16 , Issue.3 , pp. 1141-1154
    • Gray, R.J.1
  • 18
    • 0027166881 scopus 로고
    • Kaplan-Meier, marginal or conditional probability curves in summarizing competing risk failure time data?
    • Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risk failure time data? Stat Med. 1993;12(8):737-751.
    • (1993) Stat Med , vol.12 , Issue.8 , pp. 737-751
    • Pepe, M.S.1    Mori, M.2
  • 19
    • 0000336139 scopus 로고
    • Regression models and life tables
    • with discussion
    • Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187-220.
    • (1972) J R Stat Soc B , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 20
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistribution of a competing risk
    • Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Fine, J.1    Gray, R.2
  • 22
    • 33751167022 scopus 로고    scopus 로고
    • Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: Implications for the cellular target of t(15;17)
    • Chapiro E, Delabesse E, Asnafi V, et al. Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17). Blood. 2006;108(10):3484-3493.
    • (2006) Blood , vol.108 , Issue.10 , pp. 3484-3493
    • Chapiro, E.1    Delabesse, E.2    Asnafi, V.3
  • 23
    • 43549105926 scopus 로고    scopus 로고
    • Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
    • de la Serna J, Montesinos P, Vellenga E, et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008;111(7):3395-3402.
    • (2008) Blood , vol.111 , Issue.7 , pp. 3395-3402
    • De La Serna, J.1    Montesinos, P.2    Vellenga, E.3
  • 25
    • 73949119197 scopus 로고    scopus 로고
    • CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications
    • Xu N, Liu XL, DU QF, et al. CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29(8):1605-1608.
    • (2009) Nan Fang Yi Ke Da Xue Xue Bao , vol.29 , Issue.8 , pp. 1605-1608
    • Xu, N.1    Liu, X.L.2    Qf, D.U.3
  • 26
    • 76449088952 scopus 로고    scopus 로고
    • Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity
    • Ando T, Mitani N, Matsui K, et al. Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity. Int J Hematol. 2009;90(3):374-377.
    • (2009) Int J Hematol , vol.90 , Issue.3 , pp. 374-377
    • Ando, T.1    Mitani, N.2    Matsui, K.3
  • 27
    • 3843063490 scopus 로고    scopus 로고
    • Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome
    • DOI 10.1016/j.leukres.2004.01.006, PII S0145212604000372
    • Chang H, Brandwein J, Yi QL, et al. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res. 2004;28(10):1007-1011. (Pubitemid 39037332)
    • (2004) Leukemia Research , vol.28 , Issue.10 , pp. 1007-1011
    • Chang, H.1    Brandwein, J.2    Yi, Q.-L.3    Chun, K.4    Patterson, B.5    Brien, B.6
  • 28
    • 0030838704 scopus 로고    scopus 로고
    • Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21) (q22;q22)
    • Baer MR, Stewart CC, Lawrence D, et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22; q22). Blood. 1997;90(4):1643-1648. (Pubitemid 27355438)
    • (1997) Blood , vol.90 , Issue.4 , pp. 1643-1648
    • Baer, M.R.1    Stewart, C.C.2    Lawrence, D.3    Arthur, D.C.4    Byrd, J.C.5    Davey, F.R.6    Schiffer, C.A.7    Bloomfield, C.D.8
  • 29
    • 3843139439 scopus 로고    scopus 로고
    • Extramedullay acute myeloid leukemia infiltrates
    • DOI 10.1016/j.leukres.2004.03.021, PII S0145212604001808
    • Tallman MS. Extramedullary acute myeloid leukemia infiltrates. Leuk Res. 2004;28(10):1005-1006. (Pubitemid 39037331)
    • (2004) Leukemia Research , vol.28 , Issue.10 , pp. 1005-1006
    • Tallman, M.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.